Trial Profile
A Phase II Study to Assess the Effect of Intermittent Androgen Blockade in the Treatment of Advanced Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Flutamide
- Indications Prostate cancer
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms GUOG IAB
- Sponsors Abbott Laboratories; Schering-Plough
- 11 Jul 2011 New trial record